Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining in After-Hours Trading Today

NEW YORK (TheStreet) -- Tekmira Pharmaceuticals (TKMR) shares are spiking 21.57% to $25.70 in after-hours trading on Tuesday following reports that the first case of Ebola has reached the U.S., according to the CDC.

Tekmira has been working on a treatment for the deadly disease.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TKMR Chart TKMR data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

3 Stocks Pushing The Drugs Industry Lower

Tekmira Pharmaceuticals (TKMR) Weak On High Volume

Tekmira Pharmaceuticals (TKMR): Today's Weak On High Volume Stock

'Mad Money' Lightning Round: Buy, Buy, Buy Yahoo!, Not Alibaba

Jim Cramer's 'Mad Money' Recap: 'Hit and Run' Investors Are the Worst